| Literature DB >> 33730571 |
Anjali Bhat1, Haritz Irizar2, Johan Hilge Thygesen2, Karoline Kuchenbaecker3, Oliver Pain4, Rick A Adams5, Eirini Zartaloudi2, Jasmine Harju-Seppänen6, Isabelle Austin-Zimmerman2, Baihan Wang2, Rebecca Muir2, Ann Summerfelt7, Xiaoming Michael Du7, Heather Bruce7, Patricio O'Donnell8, Deepak P Srivastava9, Karl Friston10, L Elliot Hong7, Mei-Hua Hall11, Elvira Bramon12.
Abstract
Mismatch negativity (MMN) is a differential electrophysiological response measuring cortical adaptability to unpredictable stimuli. MMN is consistently attenuated in patients with psychosis. However, the genetics of MMN are uncharted, limiting the validation of MMN as a psychosis endophenotype. Here, we perform a transcriptome-wide association study of 728 individuals, which reveals 2 genes (FAM89A and ENGASE) whose expression in cortical tissues is associated with MMN. Enrichment analyses of neurodevelopmental expression signatures show that genes associated with MMN tend to be overexpressed in the frontal cortex during prenatal development but are significantly downregulated in adulthood. Endophenotype ranking value calculations comparing MMN and three other candidate psychosis endophenotypes (lateral ventricular volume and two auditory-verbal learning measures) find MMN to be considerably superior. These results yield promising insights into sensory processing in the cortex and endorse the notion of MMN as a psychosis endophenotype.Entities:
Keywords: Bayesian brain; MMN; endophenotype; gene expression; mismatch negativity; neurodevelopment; prediction error; psychosis; schizophrenia; transcriptome-wide association study
Mesh:
Substances:
Year: 2021 PMID: 33730571 PMCID: PMC7972991 DOI: 10.1016/j.celrep.2021.108868
Source DB: PubMed Journal: Cell Rep Impact factor: 9.995